n-nitrosomethyl-2-hydroxypropylamine profile

N-nitrosomethyl-2-hydroxypropylamine: RN & N1 from CA Form Index; RN given refers to parent cpd without isomeric designation; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	107719
MeSH ID	M0090845

Synonym
75411-83-5
n-nitrosomethyl-2-hydroxypropylamine
1-[methyl(nitroso)amino]propan-2-ol
nmhp
2-hydroxypropylmethylnitrosamine
2-propanol, 1-(methylnitrosoamino)-, (s)-
n-nitrosomethyl(2-hydroxypropyl)amine
brn 4955027
ccris 2015
2-propanol, 1-(methylnitrosoamino)-
n-(2-hydroxypropyl)-n-methylnitrous amide
AKOS006275495
methyl-2-hydroxypropylnitrosamine
70377-77-4
ccris 3213
unii-8es3ue4777
8es3ue4777 ,
bis(tertbutylcyclopentadienyl) tianium dichloride
DTXSID5021047
nitroso-methyl-2-hydroxypropylamine
1-(methylnitrosoamino)-2-propanol

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	6 (75.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	1 (12.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	8 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
dimethylnitrosamine Dimethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.	1.96	1	nitrosamine	geroprotector; mutagen
diisopropanolnitrosamine diisopropanolnitrosamine: experimental carcinogen. N,N-bis(2-hydroxypropyl)nitrosamine : A nitrosamine that is dipropylamine in which the hydrogen attached to the nitrogen has been replaced by a nitroso group. It is a genotoxic carcinogen, targeting the lung, liver, thyroid, and kidney.	2.65	3	diol; nitrosamine; secondary alcohol	carcinogenic agent
nitrosobis(2-oxopropyl)amine nitrosobis(2-oxopropyl)amine: structure. nitrosobis(2-oxopropyl)amine : A nitrosamine that is iminodiacetone that is substituted by a nitroso group at the N-atom. It induces pancreatic ductal adenocarcinomas in Syrian golden hamsters (other rodents are not susceptible).	2.36	2	ketone; nitrosamine	carcinogenic agent
n-nitroso(2-hydroxypropyl)(2-oxopropyl)amine N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine: structure	2.36	2
n-nitrosomethyl-2-oxopropylamine N-nitrosomethyl-2-oxopropylamine: RN & N1 from 9th CI Form Index; structure in first source	3.06	5
nadp [no description available]	2	1
nad NAD(1-) : An anionic form of nicotinamide adenine dinucleotide arising from deprotonation of the two OH groups of the diphosphate moiety.	2	1	organophosphate oxoanion	cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite

Condition	Relationship Strength	Studies
Cancer of Esophagus [description not available]	1.96	1
Angiosarcoma [description not available]	1.96	1
Cancer of Liver [description not available]	1.96	1
Experimental Hepatoma [description not available]	2.37	2
Cancer of Lung [description not available]	2.66	3
Cancer of Nose [description not available]	2.88	4
Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS.	1.96	1
Hemangiosarcoma A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)	1.96	1
Liver Neoplasms Tumors or cancer of the LIVER.	1.96	1
Lung Neoplasms Tumors or cancer of the LUNG.	2.66	3
Carcinoma, Epidermoid [description not available]	1.97	1
Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)	1.97	1
Bladder Cancer [description not available]	1.97	1
Experimental Neoplasms [description not available]	2.37	2
Papilloma, Squamous Cell [description not available]	1.97	1
Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER.	1.97	1
Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.	1.97	1
Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)	1.97	1
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.	1.97	1
Cancer of Pancreas [description not available]	2.38	2
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).	2.38	2

n-nitrosomethyl-2-hydroxypropylamine

Description

Cross-References

Synonyms (21)

Research

Studies (8)

Market Indicators

Research Demand Index: 12.13

Study Types